Weight boss? Competition for Novo Nordisk
About this episode
Since Novo Nordisk launched Wegovy in 2021, it has dominated the fast-growing market for slimming drugs. Now a new jab is eating into the Danish firm’s success. Why a slang expert thinks the first word humans ever uttered may have been a profane one. And why British sheep have got happier.
Listen to what matters most, from global politics and business to science and technology—Subscribe to Economist Podcasts+
For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account.
Hosted on Acast. See acast.com/privacy for more information.
Get every episode summarized
Each time The Intelligence from The Economist publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Intelligence from The Economist
Chainsaw sputtering: Milei’s experiment falters
The Intelligence from The Economist
School of shock: teenagers get dimmer
The Intelligence from The Economist
All right on the night: AfD’s victory
The Intelligence from The Economist
Bargaining chips: Nvidia is the bank of AI
The Intelligence from The Economist